Thousand Oaks Biopharmaceuticals
company
About
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds.
- 251 - 500
Details
- Last Funding Type
- Angel
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Mar 1, 2017
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. The company's technologies provide integrated control solutions, including the use of technical expertise to optimize the process and increase protein expression to reduce production scale, providing bio-pharmaceutical companies with personalized, chemical-defined cell culture media, formula production, technical support and ancillary services.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
5
¥700M
Thousand Oaks Biopharmaceuticals has raised a total of
¥700M
in funding over 2 rounds. Their latest funding was raised on
Mar 10, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 10, 2021 | Series C | ¥400M | 1 | — | — | Detail |
| Jul 24, 2020 | Series B | — | 1 | — | — | Detail |
| Jun 1, 2020 | Series Unknown | — | 1 | — | — | Detail |
| Jan 1, 2019 | Series A | ¥300M | 2 | — | — | Detail |
| Jan 2, 2017 | Angel | — | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
5
Thousand Oaks Biopharmaceuticals is funded by 5 investors.
Jinshi Investment
and Huaxu Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
|
|
— | Series B |
|
|
— | Series Unknown |
|
|
— | Series A |
TenYall & Sumin
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
